|
Regulation of Tumor Cell Migration by Mitochondrial Superoxide Dismutase
|
1F32CA134165-01A1
|
$52,898
|
$52,898
|
Hempel, Nadine
|
ALBANY MEDICAL COLLEGE
|
|
Molecular Biology and Therapeutics in Musculoskeletal Oncology (MBTMO) Research S
|
1R13CA135939-01
|
$10,000
|
$5,000
|
O'Keefe, Regis
|
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-09S1
|
$69,244
|
$512,591
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MT1-MMP pericellular proteolysis in malignancy
|
5R01CA077470-11
|
$335,671
|
$83,918
|
STRONGIN, ALEX
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-28
|
$3,649,220
|
$36,492
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Circulating Inhibitors of Endothelial Cell Growth
|
5R01CA064481-13
|
$311,052
|
$77,763
|
KLAGSBRUN, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
|
Diagnostic and Prognostic Sarcoma Signatures
|
5U01CA114757-04
|
$1,689,820
|
$1,267,365
|
Triche, Timothy
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Oncolytic HSV Therapy in Immunocompetent Sarcoma Models
|
5R01CA114004-03
|
$258,529
|
$258,529
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Genetics of pediatric rhabdoid tumors
|
2R01CA046274-17A2
|
$266,860
|
$88,064
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$25,450
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibitors in Src Signaling for Antitumor Therapy
|
5R01CA115674-02
|
$288,990
|
$144,495
|
Jove, Richard
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-07
|
$234,840
|
$234,840
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-12
|
$203,525
|
$10,176
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Beta-catenin as a tumor suppressor in sarcomagenesis.
|
5F32CA124078-03
|
$55,852
|
$55,852
|
MATUSHANSKY, IGOR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$119,597
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
The MiT Transcription Factor in Pediatric Malignancies
|
5R01CA102309-05
|
$299,147
|
$29,915
|
FISHER, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
Epidemiology of Syndromic GI Stromal Tumors
|
5R01CA125176-02
|
$631,925
|
$631,925
|
GARBER, JUDY
|
DANA-FARBER CANCER INSTITUTE
|
|
Immune surveillance in murine gammaherpesvirus infection
|
5R01CA103642-05
|
$279,728
|
$95,108
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
Viral Oncology Training Grant
|
2T32CA009111-31A2
|
$318,261
|
$31,826
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Hyperthermia and Perfusion Effects in Cancer Therapy
|
5P01CA042745-22
|
$2,867,786
|
$716,947
|
DEWHIRST, MARK
|
DUKE UNIVERSITY
|
|
Dissecting Mechanisms of Metastasis Through Comparative Systems Genetics
|
1R01CA138265-01
|
$463,000
|
$463,000
|
KIRSCH, DAVID
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S5
|
$100,000
|
$281,336
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
1F31CA132560-01A1
|
$27,772
|
$27,772
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection
|
1R43CA134172-01
|
$112,978
|
$112,978
|
Houghton, Michael
|
EPIPHANY BIOSCIENCES, INC.
|
|
Fox Chase Cancer Center CCOP-Research Base Program
|
3U10CA101178-03S2
|
$624,917
|
$18,748
|
ENGSTROM, PAUL
|
FOX CHASE CANCER CENTER
|
|
The Molecular Actions of Imatinib Mesylate in GISTs
|
5R01CA106588-05
|
$369,590
|
$369,590
|
GODWIN, ANDREW
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-46S2
|
$171,963
|
$249,408
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S6
|
$264,000
|
$103,047
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The East Coast AIDS and Cancer Specimen Resource
|
2U01CA066535-14
|
$1,015,469
|
$253,867
|
SILVER, SYLVIA
|
GEORGE WASHINGTON UNIVERSITY
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-32
|
$306,523
|
$76,631
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-10S1
|
$49,258
|
$239,424
|
WILLIAMS, STEPHEN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
5R01CA073585-12
|
$397,126
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$148,414
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Bim regulation by HHV-8 vIRF-1
|
1R21CA136356-01
|
$184,500
|
$184,500
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-09
|
$348,813
|
$174,407
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
HHV-8 vGPCR Signaling in Virus Biology
|
5R21CA119887-02
|
$196,800
|
$196,800
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
mTOR Signaling in Tumor Cell Motility
|
5R01CA115414-03
|
$201,997
|
$40,399
|
Huang, Shile
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
PROTON RADIATION THERAPY RESEARCH
|
2P01CA021239-29A1
|
$1,692,753
|
$101,565
|
DELANEY, THOMAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-09
|
$1,575,134
|
$157,513
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Regulation and Function of Mammalian HSF4 in vivo
|
2R01CA132640-08A1
|
$265,594
|
$132,797
|
MIVECHI, NAHID
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Anti-tumorigenic Activity of Adenovirus E1A
|
5R01CA125666-02
|
$287,850
|
$287,850
|
Routes, John
|
MEDICAL COLLEGE OF WISCONSIN
|
|
An Animal Model for Kaposi's Sarcoma
|
5K08CA103858-05
|
$133,083
|
$133,083
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Functional determinants of metastatic dormancy
|
7R01CA109182-05
|
$303,516
|
$75,879
|
AGUIRRE-GHISO, JULIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Role of Chemokine Receptor ORF74 in Angioproliferation
|
5R01CA109259-05
|
$329,470
|
$329,470
|
LIRA, SERGIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
Z01 BC 009101
|
$135,938
|
$40,781
|
Appella, Ettore
|
CCR (NCI)
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
Z01 BC 010997
|
$178,059
|
$89,030
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
Z01 BC 011004
|
$89,029
|
$8,903
|
Avital, Itzhak
|
CCR (NCI)
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
$135,022
|
Berzofsky, Jay
|
CCR (NCI)
|
|
HIV Tat Transcriptional Activation
|
Z01 BC 005753
|
$291,643
|
$58,329
|
Brady, John
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
Z01 BC 007363
|
$261,903
|
$222,618
|
Burke, Terrence
|
CCR (NCI)
|
Total relevant funding to Sarcoma, Soft (Sarcoma Subset) for this search: $50,451,328
|